Aster DM Healthcare Limited announced on January 29, 2026, that its Investment and Finance Committee has approved a proposal to acquire an additional 20.25% equity share capital of its material subsidiary, Malabar Institute of Medical Sciences Limited (MIMS). This acquisition aims to consolidate Aster DM Healthcare's shareholding in MIMS from the current 79.75% to 100%. The proposed acquisition is structured as a purchase of the equity shares from existing shareholders of MIMS. The transaction will be carried out through a letter of offer, with the actual number of shares purchased dependent on shareholder acceptance. The acquisition is not classified as a related party transaction. Malabar Institute of Medical Sciences Limited, established on February 17, 1995, is a healthcare services company operating hospitals. As of March 31, 2025, MIMS reported a turnover of ₹1,118.05 crore and a profit of ₹134.51 crore. For the fiscal years 2024 and 2023, MIMS recorded turnovers of ₹1,014.36 crore and ₹899.43 crore, respectively. The company will dispatch the letter of offer to MIMS shareholders in due course, and the transaction is estimated to be completed within three months from the dispatch date. The cash consideration for the acquisition is ₹202 per share.
